期刊
PATHOGENS
卷 8, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/pathogens8040283
关键词
neutrophils; biofilms; therapies; enzymes
类别
资金
- NIH-NEI [RO1 EY022054]
- Mason Research Fund [054285]
- Canada Foundation for Innovation [JELF 38798]
Multidrug-resistant (MDR) bacterial infections are a leading cause of mortality, affecting approximately 250,000 people in Canada and over 2 million people in the United States, annually. The lack of efficacy of antibiotic-based treatments is often caused by inability of the drug to penetrate bacterial biofilms in sufficient concentrations, posing a major therapeutic challenge. Here, we review the most recent information about the architecture of Pseudomonas aeruginosa biofilms in vivo and describe how advances in imaging and mass spectroscopy analysis bring about novel therapeutic options and challenge existing dogmas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据